Bio-Rad develops, manufactures, and markets a broad range of products and solutions for the life science research and clinical diagnostics markets. The Company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market.
Type
Public
HQ
Hercules, US
Founded
1952
Size (employees)
8,000 (est)-3%
Bio-Rad was founded in 1952 and is headquartered in Hercules, US
Report incorrect company information

Key People/Management at Bio-Rad

Norman Schwartz

Norman Schwartz

Chairman of the Board, President and Chief Executive Officer
Giovanni Magni

Giovanni Magni

EVP, Chief Strategy Officer
John Goetz

John Goetz

EVP, Chief Operating Officer
Michael Crowley

Michael Crowley

EVP, Global Commercial Operations
John Hertia

John Hertia

EVP, President, Clinical Diagnostics Group
Tim Ernst

Tim Ernst

EVP, General Counsel & Secretary
Show more

Bio-Rad Office Locations

Bio-Rad has offices in Gladesville, Wien, Pudong, København and in 22 other locations
Hercules, US (HQ)
1000 Alfred Nobel Dr
Hercules, US
4000 Alfred Nobel Dr
Gladesville, AU
Level 5, 446 Victoria Road
Wien, AT
88 Hummelgasse
Pudong, CN
3rd Floor, Build E Poly Plaza, No.18 Dong Fang Road, Pudong
København, DK
Symbion Science Park Fruebjergvej 3
Show all (27)
Report incorrect company information

Bio-Rad Financials and Metrics

Bio-Rad Revenue

Bio-Rad's revenue was reported to be $2.07 b in FY, 2016 which is a 2.4% increase from the previous period.
USD

Revenue (Q2, 2018)

1.1 b

Gross profit (Q2, 2018)

603.9 m

Gross profit margin (Q2, 2018), %

53.6%

Market capitalization (16-Aug-2018)

9.5 b

Closing stock price (16-Aug-2018)

317.9

Cash (30-Jun-2018)

403 m
Bio-Rad's current market capitalization is $9.5 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.1 b2.2 b2 b2.1 b

Revenue growth, %

2%(7%)2%

Cost of goods sold

897.8 m930.1 m

Gross profit

1.1 b1.1 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

505.1 m509.3 m536.8 m530.6 m472.8 m506.1 m470 m471.2 m516.8 m508.7 m500.1 m504.7 m551.5 m1.1 b

Cost of goods sold

220.9 m234.1 m239.6 m242.1 m202.7 m226.5 m206.5 m207.2 m236.5 m229.3 m230.1 m231.4 m249.3 m523.6 m

Gross profit

284.2 m275.3 m297.2 m288.6 m270.1 m279.6 m263.5 m264 m280.2 m279.5 m270 m273.3 m302.2 m603.9 m

Gross profit Margin, %

56%54%55%54%57%55%56%56%54%55%54%54%55%54%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

331.6 m413.3 m457.5 m456.3 m

Inventories

525 m

Current Assets

1.7 b1.7 b1.8 b1.8 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

291.8 m364.5 m384.7 m424.6 m425.7 m450.1 m507.3 m403.6 m418.7 m417.9 m291.7 m321.6 m407.3 m403 m

Accounts Receivable

383.5 m383.9 m378.9 m354.4 m342.2 m354.2 m341.5 m381.1 m366.3 m367.7 m373.4 m392.8 m430.4 m404.1 m

Inventories

523.5 m513.9 m520.6 m516 m478.4 m501 m512.7 m533.3 m541.5 m556.4 m559.8 m580.6 m612.2 m591.4 m

Current Assets

1.7 b1.8 b1.8 b1.8 b1.7 b1.7 b1.8 b1.8 b1.8 b1.9 b1.7 b1.8 b2 b2 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

77.8 m88.8 m113.1 m

Cash From Operating Activities

175.5 m273.3 m186.2 m216.4 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

31.6 m11.5 m17.8 m28.4 m17.4 m12.3 m30.3 m48.7 m12.4 m

Accounts Payable

125.5 m126.6 m

Cash From Operating Activities

40.3 m118.2 m

Cash From Investing Activities

(18.8 m)(102.7 m)
USDY, 2018

Revenue/Employee

140.9 k

Financial Leverage

1.4 x
Show all financial metrics
Report incorrect company information

Bio-Rad Online and Social Media Presence

Embed Graph
Report incorrect company information

Bio-Rad Company Life and Culture

Report incorrect company information